Santhera Pharmaceuticals Holding AG /
Santhera Closes License-Back Deal with Takeda For European Rights to Catena® in
Duchenne Muscular Dystrophy
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Liestal, Switzerland, ...
↧